Drawing based on the label description. No photo yet.
“BENICAR HCT (olmesartan / hydrochlorothiazide) is supplied as film-coated, non-scored tablets: 20 mg/12.5 mg reddish-yellow, circular, debossed with C22 on one side and plain on the other side”
C22 pill
Pill with imprint C22 is yellow, round, 9 mm and has been identified as Olmesartan Medoxomil-Hydrochlorothiazide 20 mg / 12.5 mg. It is used for high blood pressure. It is supplied by Cosette Pharmaceuticals, Inc.
Olmesartan Medoxomil-Hydrochlorothiazide 20 mg / 12.5 mg
- Imprint
- C22
- Strength
- Olmesartan Medoxomil 20 mg / Hydrochlorothiazide 12.5 mg
- Used for
- High blood pressure
- Color
- Yellow
- Shape
- Round
- Size
- 9 mm
- Score
- No score line
- Form
- Tablet, film coated
- Manufacturer
- Cosette Pharmaceuticals, Inc
- NDC
- 0713-0943, 0713-0943-30, 73190-078, 73190-078-90
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
All Olmesartan Medoxomil-Hydrochlorothiazide pills and guides
What is Olmesartan Medoxomil-Hydrochlorothiazide used for?
Olmesartan Medoxomil-Hydrochlorothiazide is used for high blood pressure.
Official uses from the US prescribing label
BENICAR HCT (olmesartan medoxomil and hydrochlorothiazide) is indicated for the treatment of hypertension, to lower blood pressure. BENICAR HCT is not indicated for the initial therapy of hypertension.
Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with BENICAR HCT.
Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).
Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly.
Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal.
Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (e.g., on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy.
BENICAR HCT may be used alone, or in combination with other antihypertensive drugs.
From the FDA-approved label on DailyMed (published Jul 15, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- One side shows C22 and the other side is plain.
- It is yellow, round, 9 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Sold under the brand name Benicar HCT.
Ingredients
Active: Olmesartan Medoxomil, Hydrochlorothiazide
Inactive: Hydroxypropyl Cellulose (1600000 Wamw), Hypromellose, Unspecified, Lactose Monohydrate, Low-Substituted Hydroxypropyl Cellulose, Unspecified, Magnesium Stearate, Microcrystalline Cellulose, Ferric Oxide Red, Talc, Titanium Dioxide, Ferric Oxide Yellow
Also distributed by
Avkare
Other pills with imprint C 22
Same imprint, different listing. Check the color, size and maker against your pill.
- C22 Hydrochlorothiazide and Olmesartan Medoxomil 12.5 mg / 20 mg Red & yellow, round, 8.5 mm Used for high blood pressure
- C 22 Quetiapine 150 mg White, capsule, 15 mm Used for bipolar disorder and schizophrenia
- C 22 Tri-Cira 21 0.25 mg / 0.035 mg / 0.18 mg / 0.035 mg / 0.035 mg / 0.215 mg Blue, round
- C 22 Tri-Cira 28 0.215 mg / 0.25 mg / 0.18 mg / 0.035 mg / 0.035 mg / 0.035 mg Blue, round
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
AA 44
Azathioprine 75 mg
Yellow, round, 10 mm
Used for multiple sclerosis and rheumatoid arthritis
-
PLIVA 471
Propranolol Hydrochloride 80 mg
Yellow, round, 10 mm
Used for high blood pressure and heart failure
-
J 7
Prochlorperazine Maleate 10 mg
Yellow, round, 8 mm
Used for anxiety and schizophrenia
-
P100
Carbamazepine 100 mg
Yellow, round, 8 mm
Used for PTSD and bipolar disorder
-
APO F50
Fluvoxamine Maleate 50 mg
Yellow, round, 9 mm
Used for depression and panic disorder
-
254 G
Ropinirole 0.5 mg
Yellow, round, 8 mm
Used for Parkinson's disease
Other Olmesartan Medoxomil-Hydrochlorothiazide pills
- SANKYO C22 Olmesartan Medoxomil-Hydrochlorothiazide 20 mg / 12.5 mg Yellow, round, 9 mm Used for high blood pressure
- MO 8 Olmesartan Medoxomil-Hydrochlorothiazide 20 mg / 12.5 mg Orange, round, 9 mm Used for high blood pressure
- Sankyo C23 Olmesartan Medoxomil-Hydrochlorothiazide 40 mg / 12.5 mg Yellow, oval, 15 mm Used for high blood pressure
- MO 9 Olmesartan Medoxomil-Hydrochlorothiazide 40 mg / 12.5 mg Orange, oval, 15 mm Used for high blood pressure
- C23 Olmesartan Medoxomil-Hydrochlorothiazide 40 mg / 12.5 mg Yellow, oval, 15 mm Used for high blood pressure
- Sankyo C25 Olmesartan Medoxomil-Hydrochlorothiazide 40 mg / 25 mg Pink, oval, 15 mm Used for high blood pressure
- MO 10 Olmesartan Medoxomil-Hydrochlorothiazide 40 mg / 25 mg Pink, oval, 15 mm Used for high blood pressure
- C25 Olmesartan Medoxomil-Hydrochlorothiazide 40 mg / 25 mg Pink, oval, 15 mm Used for high blood pressure